These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 30814361)

  • 1. Acyl-Alkyl-Phosphatidlycholines are Decreased in Saliva of Patients with Alzheimer's Disease as Identified by Targeted Metabolomics.
    Marksteiner J; Oberacher H; Humpel C
    J Alzheimers Dis; 2019; 68(2):583-589. PubMed ID: 30814361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic Biomarkers of Alzheimer's Disease as Identified in Saliva using 1H NMR-Based Metabolomics.
    Yilmaz A; Geddes T; Han B; Bahado-Singh RO; Wilson GD; Imam K; Maddens M; Graham SF
    J Alzheimers Dis; 2017; 58(2):355-359. PubMed ID: 28453477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolomics Analyses of Saliva Detect Novel Biomarkers of Alzheimer's Disease.
    Huan T; Tran T; Zheng J; Sapkota S; MacDonald SW; Camicioli R; Dixon RA; Li L
    J Alzheimers Dis; 2018; 65(4):1401-1416. PubMed ID: 30175979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted Metabolomic Analysis of Soluble Lysates from Platelets of Patients with Mild Cognitive Impairment and Alzheimer's Disease Compared to Healthy Controls: Is PC aeC40:4 a Promising Diagnostic Tool?
    Oberacher H; Arnhard K; Linhart C; Diwo A; Marksteiner J; Humpel C
    J Alzheimers Dis; 2017; 57(2):493-504. PubMed ID: 28269764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salivaomics as a Potential Tool for Predicting Alzheimer's Disease During the Early Stages of Neurodegeneration.
    François M; Karpe A; Liu JW; Beale D; Hor M; Hecker J; Faunt J; Maddison J; Johns S; Doecke J; Rose S; Leifert WR
    J Alzheimers Dis; 2021; 82(3):1301-1313. PubMed ID: 34151801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No association of salivary total tau concentration with Alzheimer's disease.
    Ashton NJ; Ide M; Schöll M; Blennow K; Lovestone S; Hye A; Zetterberg H
    Neurobiol Aging; 2018 Oct; 70():125-127. PubMed ID: 30007161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma metabolomic profiling of amino acids and polar lipids in Iranian obese adults.
    Bagheri M; Djazayery A; Farzadfar F; Qi L; Yekaninejad MS; Aslibekyan S; Chamari M; Hassani H; Koletzko B; Uhl O
    Lipids Health Dis; 2019 Apr; 18(1):94. PubMed ID: 30967146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Models including plasma levels of sphingomyelins and phosphatidylcholines as diagnostic and prognostic biomarkers of endometrial cancer.
    Knific T; Vouk K; Smrkolj Š; Prehn C; Adamski J; Rižner TL
    J Steroid Biochem Mol Biol; 2018 Apr; 178():312-321. PubMed ID: 29360580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Periodontal Status and Saliva Metabolic Signature in Patients with Alzheimer's Disease.
    Yang Y; Lv J; Bai H; Ren L; Yang J; Ding Y; Liu C; Chen X
    J Alzheimers Dis; 2023; 95(2):603-613. PubMed ID: 37424468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers for Alzheimer's Disease in Saliva: A Systematic Review.
    Gleerup HS; Hasselbalch SG; Simonsen AH
    Dis Markers; 2019; 2019():4761054. PubMed ID: 31191751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain and blood metabolome for Alzheimer's dementia: findings from a targeted metabolomics analysis.
    Huo Z; Yu L; Yang J; Zhu Y; Bennett DA; Zhao J
    Neurobiol Aging; 2020 Feb; 86():123-133. PubMed ID: 31785839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current State of Saliva Biomarkers for Aging and Alzheimer's Disease.
    François M; Bull CF; Fenech MF; Leifert WR
    Curr Alzheimer Res; 2019; 16(1):56-66. PubMed ID: 30345919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered levels of acylcarnitines, phosphatidylcholines, and sphingomyelins in peritoneal fluid from ovarian endometriosis patients.
    Vouk K; Ribič-Pucelj M; Adamski J; Rižner TL
    J Steroid Biochem Mol Biol; 2016 May; 159():60-9. PubMed ID: 26921767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Next-generation biomarker discovery in Alzheimer's disease using metabolomics - from animal to human studies.
    Hurtado MO; Kohler I; de Lange EC
    Bioanalysis; 2018 Sep; 10(18):1525-1546. PubMed ID: 30198770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma metabolic profiling of mild cognitive impairment and Alzheimer's disease using liquid chromatography/mass spectrometry.
    Liu Y; Li N; Zhou L; Li Q; Li W
    Cent Nerv Syst Agents Med Chem; 2014; 14(2):113-20. PubMed ID: 25515716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of phosphatidylcholines and sphingomyelins as biomarkers for ovarian endometriosis.
    Vouk K; Hevir N; Ribić-Pucelj M; Haarpaintner G; Scherb H; Osredkar J; Möller G; Prehn C; Rižner TL; Adamski J
    Hum Reprod; 2012 Oct; 27(10):2955-65. PubMed ID: 22859507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Widely targeted metabolomics of Alzheimer's disease postmortem cerebrospinal fluid based on 9-fluorenylmethyl chloroformate derivatized ultra-high performance liquid chromatography tandem mass spectrometry.
    Muguruma Y; Tsutsui H; Noda T; Akatsu H; Inoue K
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Aug; 1091():53-66. PubMed ID: 29852382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma metabolite profiles of Alzheimer's disease and mild cognitive impairment.
    Wang G; Zhou Y; Huang FJ; Tang HD; Xu XH; Liu JJ; Wang Y; Deng YL; Ren RJ; Xu W; Ma JF; Zhang YN; Zhao AH; Chen SD; Jia W
    J Proteome Res; 2014 May; 13(5):2649-58. PubMed ID: 24694177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of altered phosphatidylcholine metabolism in Alzheimer's disease.
    Whiley L; Sen A; Heaton J; Proitsi P; García-Gómez D; Leung R; Smith N; Thambisetty M; Kloszewska I; Mecocci P; Soininen H; Tsolaki M; Vellas B; Lovestone S; Legido-Quigley C;
    Neurobiol Aging; 2014 Feb; 35(2):271-8. PubMed ID: 24041970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum metabolites and risk of myocardial infarction and ischemic stroke: a targeted metabolomic approach in two German prospective cohorts.
    Floegel A; Kühn T; Sookthai D; Johnson T; Prehn C; Rolle-Kampczyk U; Otto W; Weikert C; Illig T; von Bergen M; Adamski J; Boeing H; Kaaks R; Pischon T
    Eur J Epidemiol; 2018 Jan; 33(1):55-66. PubMed ID: 29181692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.